Dihydropyrimidine Dehydrogenase Testing for Fluoropyrimidine Toxicity


( Last Updated : February 5, 2021)
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1549-000

Details


Question


  1. What are the evidence-based guidelines regarding the use of dihydropyrimidine dehydrogenase testing before treatment with fluoropyrimidine (i.e., 5-fluorouracil and capecitabine) in patients being treated for cancer?


Key Message

One evidence-based guideline was identified regarding the use of dihydropyrimidine dehydrogenase testing before treatment with fluoropyrimidine (i.e., 5-fluorouracil and capecitabine) in patients being treated for cancer.